Diabetic Gastroparesis Treatment Market Global Size
To arrive at the Diabetic Gastroparesis Treatment Market size, the report considers revenue from the sales of diabetic gastroparesis products in key markets across five geographies.
To arrive at the Diabetic Gastroparesis Treatment Market size, the report considers revenue from the sales of diabetic gastroparesis products in key markets across five geographies.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
Report Media Releases<br />
<strong>Global</strong> <strong>Diabetic</strong> <strong>Gastroparesis</strong> <strong>Treatment</strong> <strong>Market</strong> to be<br />
Valued at US$ 3,769.3 Mn by 2024; Rising demand for<br />
Antiemetic Agents expected to Boost <strong>Market</strong> Growth<br />
According to the latest market report published by Persistence <strong>Market</strong> Research titled “<strong>Diabetic</strong><br />
<strong>Gastroparesis</strong> <strong>Treatment</strong> <strong>Market</strong>: <strong>Global</strong> Industry Analysis and Forecast, 2016 – 2024”, revenue<br />
from the global diabetic gastroparesis treatment market is projected to register a CAGR of 4.1%<br />
during the forecast period (2016–2024). <strong>Diabetic</strong> gastroparesis is the symptom of delayed gastric<br />
emptying affecting patients suffering from Type-1 and Type-2 diabetes. The disease primarily<br />
has no cure but its symptoms are treatable via various types of drugs and devices. The global<br />
diabetic gastroparesis treatment market was valued at US$ 2,650 Mn in 2015, which is expected<br />
to increase to US$ 3,769.3 Mn by 2024. The report analyzes the global diabetic gastroparesis<br />
treatment market in terms of market value on the basis of product type, disease indication, and<br />
distribution channel; and provides information regarding regional market dynamics, regulations,<br />
current trends, market estimations, and forecast.<br />
Browse Complete Research Here @ http://www.persistencemarketresearch.com/marketresearch/diabetic-gastroparesis-market.asp<br />
Rising prevalence of Type-1 and Type-2 diabetes with high unmet medical needs, growing<br />
demand for minimally invasive treatment for refractory gastroparesis, and availability of<br />
reimbursement for in-patient hospital stays are driving growth of the global diabetic gastroparesis<br />
treatment market. Increasing use of diabetic gastroparesis drugs to control symptoms such as<br />
nausea and vomiting is anticipated to fuel growth of the global diabetic gastroparesis treatment<br />
market over the forecast period. However, usage of non-prescription drugs to control the<br />
symptoms restricts diagnosis of stage 1 and stage 2 gastroparesis. Lack of clinical evidence on<br />
improvement offered by prescription drugs and termination of clinical trials are factors expected<br />
to hamper growth of the global diabetic gastroparesis treatment market over the forecast period.<br />
Request for Table of Content Here @ http://www.persistencemarketresearch.com/marketresearch/diabetic-gastroparesis-market/toc<br />
The global diabetic gastroparesis treatment market has been segmented on the basis of product<br />
type into drugs and surgical treatment products; on the basis of disease indication into<br />
compensated gastroparesis and gastric failure; and on the basis of distribution channel into<br />
<strong>Global</strong> <strong>Diabetic</strong> <strong>Gastroparesis</strong> <strong>Treatment</strong> 2016-2024
Change language